The powder is known to be administered to diabetic patients by many ayurvedic physicians to cure the metabolic disorder. However, scientific evidence on the antidiabetic activity of the powder as such is lacking. The individual constants in the powder have been attributed several medicinal properties from very early times. T. Cordifolia has been mentioned in Ayurvedic literature as an ingredient in several compound preparations used in general debility, dyspepsia, fever and urinary disorders . Antiviral effect of the plant against Ranikhet disease of the poultry has been reported by many workers (Chopra et. al 1958 , Dastur, 1951 Kirtikar et al 1935) . The active principle of the drug has been found to produce in vitro inhibitory effect on
INTRODUCTION
Amrithadi churnam is a compound ayurvedic preparation made from five constituent drugs viz. Tyinospora cordifolia (San. Guduchi), Salacia prenoides (San.
Ekanayakam,)
Curuma longa (San. Haridra), Tribulus terrestris (San. Goksura) and Phyllanthus emblica (San.Amalaki). The powder is known to be administered to diabetic patients by many ayurvedic physicians to cure the metabolic disorder. However, scientific evidence on the antidiabetic activity of the powder as such is lacking. The individual constants in the powder have been attributed several medicinal properties from very early times. T. Cordifolia has been mentioned in Ayurvedic literature as an ingredient in several compound preparations used in general debility, dyspepsia, fever and urinary disorders (Wealth of India, 1976). Antiviral effect of the plant against Ranikhet disease of the poultry has been reported by many workers (Chopra et. al 1958 , Dastur, 1951 Kirtikar et al 1935) . The active principle of the drug has been found to produce in vitro inhibitory effect on
Mycobacterium tuberculosis
(Annual report, ICMR. 1968 -69). The acute and chronic effects of feeding plant extracts on blood sugar, glucose tolerance etc. were studied in animals and the aqueous and alcoholic extracts were found to reduce blood sugar levels.
The drug has a suggested effect on endogenous insulin secretion and inhibition of peripheral glucose release. (Mehta et al., 1965 , Gupta et al 1967 . Roots of Salaciaprenoides have been reported to be used as an antidiabetic drug in the indigenous system of medicine.
The medicinally active components of the root bark have been characterized by several workers (Dash & Bedi 1967; Bhatnagar et al, 1954 , Ramanathan et al, 1960 Krishnan et al, 1967; Pillay et al 1957) . Earlier studies conducted with three species of Salacia also indicated the hypoglycemic activity of the plant . C. longa has been mentioned in ancient literature as a stomachic, tonic and blood purifier. (Wealth of India, 1950). Chemical characterization of the rhizome was made by several workers (Health Bulletin, 1941; Mayer 35 al, 1943) and choleretic action of its essential oil has been attributed to P-tolymlthylcarbional T. Terrestris is being used for the treatment of renal calculus and painful micturition. The diuretic activity of the drug has been studied in detail. (Santhakumar et al, 1967) . The seeds were reported to contain an alkaloid to which the diuretic effect was ascribed.
(Wealth of India. 1976). The root extract is a constituent of many Ayurvedic preparations like Dasamoolarishta and Amrithaprasa ghritha prescribed for several disease. (Koman, 1919 Rama Rao, 1914 Kirtika et al, 1935 , Pradhan, 1963 . The medicinal properties of Amla fruit (Kirtikar et al, 1935; Nadkarni, 1914; Koman, 1918) are well documented and it form constituent of many Ayurvedic preparations.
Although individual components of Amrithadi churnam have been ascribed for many therapeutic effects, the synergistic action of remains relatively unknown. The antidiabetic action of the powder was studied in albino rats in comparison to the effect of standard hypoglycemic drugs tolbutamide and phenformin.
MATERIALS AND METHODS
Adult albinos rats (Sprage-Dowley strain) weighing 180 -200g. were used for the study. Before the start of the experiment animals were fasted overnight and blood sugar values were noted.
Blood was collected by the eye puncture method using clean capillary tube. The animals were fed standard feed and water was available ad-libitum.
Healthy male albino rats from the colony were made diabetic by the single rapid ip injection of 120 mg/kg body weight of alloxan monohydrate. (5% w/v in distilled water) After 3 days the fasting blood sugar levels were rechecked and diabetic animals were selected on the elevated sugar values. These were grouped into six each containing 5 rats. Group Administered distilled water served as control Group II-IV were given Amrthidai churnam at dose levels of 50mg. 100mg and 200 mg/kg. body weight. Group V and VI were given tolbutamide (250 mg/kg. body weight). Group V and VI were given tolbutamide (250 mg/kg b.w) and phenformin (20 mg/kg b.w) served as reference standards. Respective drugs were administered for 4 weeks and the overnight fasted animals were sacrificed. Blood and liver samples were collected for the biochemical analyses.
Blood sugar was determined by the method of Astoor and King (1954). Serum total proteins were determined using Biuret method (1945).
Serum and liver transaminase (GOT and GPT) were determined by the method of Reitman & Frankel (1957) .
Blood hematocrit was recorded following standard procedures.
RESULTS AND DISCUSSION
The initial fasting blood sugar values of alloxan diabetic rats ranged from 206 -305 mg/ 100 ml. (Table I ). It was found that administration of Amrithadi churnam at a dose level of 50 mg/kg b.w. could bring down the blood sugar level to 152.7 ± 9.99 mg/100ml. A dose level of 100 mg/kg b.w. could significantly reduce the hyperglycemia observed before the treatment (Table. I ). However the higher dose level of 200 mg/kg b.w. could not further bring down the blood sugar. Its effective was comparable to the lowest dose level tried. From the studies it could be established that 100 mg/kg b.w. was the optimum dose level in rats. Only non significant hypoglycemeic changes were noted in rats given tolbutamide while phenoformin exhibited a significant hypoglycemic effect (Table I) . This was observed from the results of earlier studies also (Nair et. al. 1986 ).
Serum and liver protein changes in rats given Amrithadi churnam are given in Table  II . It could be seen that at the lower dose levels the drug produced no effect on serum protein levels. However the higher dose level produced significant decrease in the serum protein liver protein remained unaffected at all dose levels (Table II) .
The pattern of changes in serum and liver transaminase depicted in Table III to show that the drug did not alter the serum and liver glutamate oxalo acetate transaminase activity. While the serum GPT remained unaffected at the three dose levels tried, liver GPT activity was considerably reduced at the lowest dose level 50 mg/kg b.w. tried. However the optimum dose level of the drug as judged from the maximum hypoglycemic effect being 100mg / kg b.w, this decrease in GPT activity of liver has little significance.
Tolbutamide was found to be ineffective in alloxan diabetic animals. Since alloxan administration has bee reported to damage the B-cells of langerhans of pancreas, the site of insulin release. The hypoglycemic effect of tolbutamide is mainly through enhancing insulin release in normal diabetic condition. (Jenkin's et al; 1978) Phenformin on the other hand increase glucose uptake by peripheral tissues and accelerates anaerobic glycolysis through an uncoupling of exudative phosphorylation (Nair and Santhakumar,1986 ).
The hypoglycemic effect of Amrithati churnam observed in alloxan diabetic animals indicates an extract pancreatic action of the drug. The exact mode of action of the drug needs further investigations. The serum and liver protein levels as well as transaminase activities indicate the nontoxic nature of the drug at lower level of 50 mg and 100 mg/kg b.w.
Also the blood haemtocrit indicates the non-toxic nature of thedrug (Table IV) . The study shows that Amrithadi churnam has got potent antidiabetic / hypolycaemic effect at the optimum dose level of 100 mg/kg b.w in rats. 
